Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$19.02 - $24.95 $3.8 Million - $4.99 Million
-200,000 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $2.26 Million - $2.99 Million
-100,000 Reduced 33.33%
200,000 $4.57 Million
Q4 2017

Feb 14, 2018

SELL
$18.0 - $30.0 $11.9 Million - $19.8 Million
-660,000 Reduced 68.75%
300,000 $7.86 Million
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $20.3 Million - $24.1 Million
960,000
960,000 $21.6 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Miura Global Management, LLC Portfolio

Follow Miura Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miura Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miura Global Management, LLC with notifications on news.